For patients with clinical obesity, type 2 diabetes, or cardiovascular risk that requires rapid medical intervention, they remain one of the most effective tools available
Metformin remains unchanged, as Richard tolerates it well
After a median follow up of 3.8 years, 3-point MACE in LEADER was reduced by 13% (HR =0.87, P=0.01 for superiority) (Figure 3) and, unlike the EMPA REG OUTCOME study, all three individual components of MACE (MI, stroke, CV mortality) contributed to the cardiovascular benefit including reduced CV mortality
Acetylcysteine Solution, USP is available in rubber stoppered glass vials containing 4, or 30 mL
Its not considered addictive like opioids or benzodiazepines, but dependence/withdrawal can occur if stopped abruptlytaper with a clinician
10.1016/j.envres.2020.109453 41 LiuH.-M.ChengM.-Y.XunM.-H.ZhaoZ.-W.ZhangY.TangW.et al (2023)